Finance

Lists
Why is 4155 up 9,48%?
Dive Deeper
4155:TPE
OK Biotech Co Ltd
NT$17,90
+9,48%
(+1,55) 1D
6 Nov., 13:30:05 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4155...
Open
NT$15,65
High
NT$17,90
Low
NT$15,25
Mkt. cap
2,24 mjd
Avg. vol.
610,26 k
Volume
1,49 m
Dividend
1,68%
Quarterly dividend
NT$0,08
Ex-dividend date
20 Okt. 2026
P/E ratio
9,61
52-wk high
NT$18,41
52-wk low
NT$14,34
EPS
NT$1,86
Shares outstanding
74,63 m
No. of employees
62
Open
NT$15,65
High
NT$17,90
Low
NT$15,25
Mkt. cap
2,24 mjd
Avg. vol.
610,26 k
Volume
1,49 m
Dividend
1,68%
Quarterly dividend
NT$0,08
Ex-dividend date
20 Okt. 2026
P/E ratio
9,61
52-wk high
NT$18,41
52-wk low
NT$14,34
EPS
NT$1,86
Shares outstanding
74,63 m
No. of employees
62
News stories
From web sources and news partners
About OK Biotech Co Ltd
CEOJames Lai
Employees62
Founded2004
Headquarters-
SectorHealth Care
IndustryMedical device
Websiteokbiotech.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
379,58 m
337,58 m
383,78 m
436,13 m
Cost of goods sold
247,12 m
244,34 m
261,14 m
305,92 m
Cost of revenue
247,12 m
244,34 m
261,14 m
305,92 m
Research and development expenses
9,66 m
22,76 m
8,89 m
15,17 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71,13 m
50,12 m
60,12 m
71,50 m
Operating expense
80,53 m
36,72 m
62,54 m
78,54 m
Total operating expenses
327,65 m
281,06 m
323,68 m
384,46 m
Operating income
51,94 m
56,52 m
60,10 m
51,67 m
Other non operating income
2,50 m
-1,93 m
4,69 m
10,59 m
EBT including unusual items
84,84 m
69,51 m
74,75 m
64,00 m
EBT excluding unusual items
83,43 m
70,99 m
75,71 m
62,76 m
Income tax expense
-1,54 m
10,36 m
11,18 m
14,94 m
Effective tax rate
-1,82%
14,91%
14,96%
23,35%
Other operating expenses
-
-
-
-
Net income
85,19 m
53,54 m
55,35 m
48,16 m
Net profit margin
22,44%
15,86%
14,42%
11,04%
Earnings per share
-
-
-
-
Interest and investment income
369,00 k
1,01 m
322,00 k
2,02 m
Interest expense
-2,62 m
-3,65 m
-1,83 m
-1,76 m
Net interest expenses
-2,25 m
-2,64 m
-1,51 m
262,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
71,84 m
76,42 m
80,17 m
71,72 m
Gain or loss from assets sale
43,00 k
294,00 k
2,00 m
6,00 k
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme